NAC+ 600 mg
Kal

NAC+ 600 mg

C
N+ Score70
Joint & BoneServing: 1 Tablet(s)Type: Other Combinations

NAC+ 600 mg by Kal is a combination supplement within the Joint & Bone category, though its primary active ingredient is N-Acetyl Cysteine (NAC). This product achieves an N+ Score of 70, resulting in a 'C' grade, signifying a good quality formulation. It provides N-Acetyl Cysteine at 600mg per serving, alongside Riboflavin (10mg) and Molybdenum (150mcg), both of which are present at clinically studied dosages. Calcium, however, is noted as underdosed in this formulation. With a total of five ingredients and 100% label transparency, consumers can clearly see the amounts of each component. This supplement may appeal to individuals looking for NAC combined with specific B vitamins and minerals for general wellness support.

About This Product

NAC+ 600 mg by Kal is a joint & bone supplement containing 5 active ingredients. It has earned an N+ Score of 70/100 (Grade C).

Notable clinical-dose ingredients include Riboflavin, Molybdenum.

N+ Score Breakdown

Ingredient Adequacy67/100

Are key ingredients present at clinically effective doses based on research?

Formula Completeness25/100

Does the product include all expected ingredients for its supplement category?

Label Transparency100/100

Are individual ingredient amounts clearly disclosed without proprietary blends?

Ingredient Diversity100/100

Does the formula include a breadth of beneficial compounds from multiple pathways?

Strengths

  • +Fully transparent label with individual ingredient amounts disclosed
  • +Broad ingredient diversity exceeding category norms
  • +2 ingredient(s) at clinical dose levels

Weaknesses

  • Missing several expected ingredients for its category

Ingredient Analysis (5 ingredients)

IngredientAmountDose Adequacy
Riboflavin10.000 mgOptimal
Calcium7.000 mgUnder
Total Carbohydrates1.000 Gram(s)N/A
Molybdenum150.000 mcgOptimal
N-Acetyl Cysteine600.000 mgN/A

Clinical ranges based on NIH ODS Fact Sheets and peer-reviewed research. Status indicates whether the amount meets evidence-based thresholds.